BVBalakrishnan Vijayakumar

Balakrishnan Vijayakumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Balakrishnan Vijayakumar has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In vivo evaluation of three isoxazolines against Cx. tritaeniorhynchus (Diptera: Culicidae): A novel approach to control Japanese encephalitis vector

    by Smrutidhara Dash, Sundharesan Munusamy, Balamurugan Mookiah, Vijayakumar Balakrishnan, Appadurai Daniel Reegan, Nisha Mathew, Manju Rahi, Ashwani Kumar

  • Open Access

    Insecticide‐treated nets distribution campaign: Physical integrity, usage and sustainable disposal of end‐of‐life insecticide‐treated nets under operational settings in Odisha, India

    by A. N. Shriram, Mustafa Baig, D. K. Panigrahi, B. Vijayakumar, S. S. Sahu, Tatvadarshi Dash, Ashwani Kumar

    Objectives: Prior to 2017, Odisha accounted for 50% of all Plasmodium falciparum cases in India. The ‘National Strategic Plan’ for malaria elimination had distributed 11.3 million insecticidal treated nets (ITNs) to 23 million individuals in Odisha's 17 malaria‐endemic districts by 2017. In 2021, the National Centre for Vector‐Borne Disease Control replaced end‐of‐life ITNs. India needs official regulations on end‐of‐life ITNs collection and disposal mechanisms. A pilot study was undertaken to understand community practices and perceptions on end‐of‐life ITNs.Methods: The 2021 study was conducted during mass ITN replenishment in a campaign mode at Koksara Community Health Centre in Odisha's Kalahandi region. ITN conditions were evaluated using structured questionnaires and household interviews. End‐of‐life ITNs were evaluated for chemical analyses. Door‐to‐door assessments of net conditions included noting their presence, attrition rates and fabric integrity. Officials from the Department of Health were consulted on eco‐friendly disposal techniques.Results: In the study region, 6022 ITNs were distributed, of which 5879 (97.6%) were available and 143 (2.4%) were reported as missing 43 months after the campaign (2017). One net per 2.1 persons was distributed. Of the 5879 ITNs, 84.2% were torn, 931 (15.8%) were in good condition and 3472 (59.1%) were serviceable. When combining the ITNs in good condition and those that were serviceable, 74.9% were deemed usable. A total of 3050 respondents were interviewed. Most respondents (98%, 2935/3050) were willing to exchange old ITNs for new ones (92.5%, 5437/5879) when replaced with new ones, highlighting the need for a disposal mechanism at both programme and household levels. Additionally, 61.6% of respondents chose to keep their ITNs, while others repurposed them (7.3% for covering items, 3.0% for fencing, 4.6% for nursery saplings, 5.6% for fishing, 0.4% for other uses). The end‐of‐life PermaNet 2.0 nets contained an average of 0.33 ± 0.35 g/kg (15.3 mg/m2), while the new nets contained an average of 1.4 g/kg ± 25% (55 mg/m2).Conclusions: Community input on end‐of‐life ITN disposal contributes to the development of evidence‐based decision support materials, facilitating the formulation of a strategy for the systematic collection and safe disposal of used nets. The lack of an operationally viable solution for the secure disposal of end‐of‐life ITNs within the National Programs underscores the urgent need for a comprehensive policy framework.


  • Open Access

    Molecular xenomonitoring of Wuchereria bancrofti infection in three different evaluation settings of lymphatic filariasis elimination programme in India

    by Venkatesan Vasuki, Kaliannagounder Krishnamoorthy, Swaminathan Subramanian, Candasamy Sadanandane, Ramalingam Balasubramaniyan, Neelavathi Sivagnaname, Veerappan Padmanaban, Balakrishnan Vijayakumar, Vinayagam Sundarraj, Chokkalingam Palaniswamy, et al.


  • Open Access

    Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India – a cross sectional study

    by Raja Jeyapal Dinesh, Rajendran Dhanalakshmi, Priskilla Johnson Jency, Adinarayanan Srividya, Balakrishnan Vijayakumar, Ashwani Kumar

    Background: Vaccine hesitancy is a complex phenomenon that threatens global health. Present-day communication technology has paved the way for self-education but also contributed to the infodemic surrounding vaccination. This has resulted in pockets of people who are reluctant, refuse recommended vaccinations, or choose to delay being vaccinated. The present study was designed to estimate the magnitude of hesitancy towards the COVID-19 vaccination and determine its associated factors in the community. Methods: This cross-sectional study was conducted among 776 adults aged ≥ 18 years in 15 clusters in Puducherry district, India, between March 2022 and May 2022. Face-to-face interviews were conducted using a validated, structured questionnaire. Socio-demographic variables, co-morbidities, attitudes towards vaccination, etc., were expressed as frequencies and percentages. Vaccine hesitancy was dichotomized with the median score as the cut-off and reported as a proportion with a 95% confidence interval. Univariate and multivariate analyses were carried out to determine the factors associated with vaccine hesitancy. Results: The mean age of participants was 43.3 ± 14.8 years, with the majority being female (67.0%). Nearly 92.4%, 74.4%, and 0.5% of participants received their first, second, and precautionary doses, respectively, during the study period. Among the unvaccinated, 93.2% were unwilling to receive any dose of vaccination. More than half of the participants were hesitant towards vaccination, according to the vaccine hesitancy scale. Participants aged above 45 years were less hesitant, while those educated up to school level, belonging to the upper socio-economic class, never tested for COVID-19 in the past, and having a negative attitude towards vaccination were significantly associated with higher vaccine hesitancy. Conclusions: It is imperative to address vaccine hesitancy by alleviating existing fears and misconceptions in the community through efficient communication strategies to win the fight against current as well as future public health emergencies.


  • Open Access

    Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review

    by Adinarayanan Srividya, Swaminathan Subramanian, Purushothaman Jambulingam, Balakrishnan Vijayakumar, Jeyapal Dinesh Raja

    Lymphatic filariasis (LF) is targeted for elimination by the year 2020. The Global Programme for Elimination of LF (GPELF) aims to achieve elimination by interrupting transmission through annual mass drug administration (MDA) of albendazole with ivermectin or diethylcarbamazine. The program has successfully eliminated the disease in 11 of the 72 endemic countries, putting in enormous efforts on systematic planning and implementation of the strategy. Mapping areas endemic for LF is a pre-requisite for implementing MDA, monitoring and evaluation are the components of programme implementation. This review was undertaken to assess how the mapping and impact monitoring activities have evolved to become more robust over the years and steered the LF elimination programme towards its goal. The findings showed that the WHO recommended mapping strategy aided 17 countries to delimit, plan and implement MDA in only those areas endemic for LF thereby saving resources. Availability of serological tools for detecting infection in humans (antigen/antibody assays) and molecular xenomonitoring (MX) in vectors greatly facilitated programme monitoring and evaluation in endemic countries. Results of this review are discussed on how these existing mapping and monitoring procedures can be used for re-mapping of unsurveyed and uncertain areas to ensure there is no resurgence during post-MDA surveillance. Further the appropriateness of the tests (Microfilaria (Mf)/antigenemia (Ag)/antibody(Ab) surveys in humans or MX of vectors for infection) used currently for post-MDA surveillance and their role in the development of a monitoring and evaluation strategy for the recently WHO recommended triple drug regimen in MDA for accelerated LF elimination are discussed.